Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.50
Delayed Data
As of May 22
 +0.0049 / +0.99%
Today’s Change
0.48
Today|||52-Week Range
3.98
-68.75%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 4.63, with a high estimate of 5.00 and a low estimate of 4.25. The median estimate represents a +825.00% increase from the last price of 0.50.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$14.5K
Reporting Date
May 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.08%
 
 
 
 
 
 
Growthannually 56.33%
 
 
 
 
 

Sales

Growthquarterly 3.57%
 
 
 
 
 
 
Growthannually -26.76%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account